Morepen Begins Commercial Supplies under INR 825 Crore CDMO Contract
Morepen has started commercial supplies under its INR 825 crore CDMO mandate, completing the first INR 50 crore dispatch in Q1 FY2026-27 and strengthening its contract manufacturing business.
Indian Pharma | 01/07/2026 | By News Bureau
Indian Pharma Faces Limited Impact from US Tariffs on Patented Medicines
The announcement by Donald J Trump to impose a 100 Percent tariff on patented pharmaceuticals and their ingredients is expected to have a limited immediate impact on the Indian pharmaceutical industry, according to industry experts.
Indian Pharma | 04/04/2026 | By Darshana | 164
Indian Pharma Firms Selected to Supply Key Generic Drugs in China
Several Indian pharmaceutical companies—including Cipla Ltd, Hetero Labs Limited, Natco Pharma Limited, and Annora Pharma Private Limited—have won bids to supply generic medicines to public hospitals in China under the country’s volume-based procurement (VBP) programme.
Indian Pharma | 12/11/2025 | By Darshana | 589
India’s small and mid-sized pharmaceutical manufacturers are raising alarms over new good manufacturing practice (GMP) and bio-equivalence mandates, warning that the regulations could widen the gap between large companies and micro, small, and medium enterprises (MSMEs).
Indian Pharma | 13/10/2025 | By Darshana | 730
PM Narendra Modi lays foundation stone of bulk drug park in Una, HP
Raw materials for medicine manufacturing will be produced in Himachal Pradesh
Indian Pharma | 13/10/2022 | By Sudeep Soparkar | 462
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy